AU2003278084A1 - Benzo(d)azepine derivatives for the treatment of neurological and psychiatric disorders - Google Patents

Benzo(d)azepine derivatives for the treatment of neurological and psychiatric disorders

Info

Publication number
AU2003278084A1
AU2003278084A1 AU2003278084A AU2003278084A AU2003278084A1 AU 2003278084 A1 AU2003278084 A1 AU 2003278084A1 AU 2003278084 A AU2003278084 A AU 2003278084A AU 2003278084 A AU2003278084 A AU 2003278084A AU 2003278084 A1 AU2003278084 A1 AU 2003278084A1
Authority
AU
Australia
Prior art keywords
neurological
benzo
treatment
psychiatric disorders
azepine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003278084A
Inventor
Thomas Daniel Heightman
David Matthew Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003278084A1 publication Critical patent/AU2003278084A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
AU2003278084A 2002-10-16 2003-10-14 Benzo(d)azepine derivatives for the treatment of neurological and psychiatric disorders Abandoned AU2003278084A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0224083.6A GB0224083D0 (en) 2002-10-16 2002-10-16 Novel compounds
GB0224083.6 2002-10-16
PCT/EP2003/011421 WO2004035544A1 (en) 2002-10-16 2003-10-14 Benzo[d]azepine derivatives for the treatment of neurological and psychiatric disorders

Publications (1)

Publication Number Publication Date
AU2003278084A1 true AU2003278084A1 (en) 2004-05-04

Family

ID=9946028

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003278084A Abandoned AU2003278084A1 (en) 2002-10-16 2003-10-14 Benzo(d)azepine derivatives for the treatment of neurological and psychiatric disorders

Country Status (3)

Country Link
AU (1) AU2003278084A1 (en)
GB (1) GB0224083D0 (en)
WO (1) WO2004035544A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
MXPA05006567A (en) 2002-12-20 2005-08-16 Glaxo Group Ltd BENZO aC¦ D!AZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS.
GB0408083D0 (en) * 2004-04-08 2004-05-12 Glaxo Group Ltd Novel compounds
AR051919A1 (en) * 2004-06-18 2007-02-21 Glaxo Group Ltd COMPOSITE DERIVED FROM BENZAZEPINA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCEDURES TO PREPARE THE COMPOUND
CA2601644A1 (en) 2005-03-14 2006-09-21 Glaxo Group Limited Fused thiazole derivatives having affinity for the histamine h3 receptor
GB0513886D0 (en) 2005-07-06 2005-08-10 Glaxo Group Ltd Novel compounds
US7514433B2 (en) * 2006-08-03 2009-04-07 Hoffmann-La Roche Inc. 1H-indole-6-yl-piperazin-1-yl-methanone derivatives
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116824D0 (en) * 1991-08-05 1991-09-18 Smithkline Beecham Corp Chemical compounds
CO5140073A1 (en) * 1998-10-08 2002-03-22 Smithkline Beecham Plc DERIVATIVES OF 2,3,4,5-TETRAHIDRO-1H-3-BENZAPINA
CA2347095A1 (en) * 1998-10-16 2000-04-27 Takeda Chemical Industries, Ltd. Nitrogen-containing condensed heterocyclic derivatives, their production and agent
PT1311482E (en) * 2000-08-08 2007-04-30 Ortho Mcneil Pharm Inc Non-imidazole aryloxypiperidines as h3 receptor ligands
KR20030045187A (en) * 2000-11-14 2003-06-09 스미스클라인비이참피이엘시이 Tetrahydrobenzazepine Derivatives Useful as Modulators of Dopamine D3 Receptors(Antipsychotic Agents)
WO2002076925A2 (en) * 2001-03-23 2002-10-03 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses

Also Published As

Publication number Publication date
GB0224083D0 (en) 2002-11-27
WO2004035544A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
HK1085647A1 (en) Benzo [d]azepine derivatives for the treatment of neurological disorders
HK1078858A1 (en) Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
AU8187701A (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
HUP0105215A3 (en) Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
AU2003249983A1 (en) Piperidines useful for the treatment of central nervous system disorders
AU6462500A (en) Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
AU2002356525A1 (en) Substituted amines for the treatment of neurological disorders
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AU6910600A (en) Methods for the treatment of mental disorders
AU3977700A (en) Method of treating neurological disorders
AU2001271887A1 (en) Methods for diagnosis and treatment of psychiatric disorders
AU5908300A (en) Prevention and treatment of amyloid-associated disorders
AU1356201A (en) Treatment of hyperproliferative disorders
AU2002229452A1 (en) Method of treating neurological disorders using acetone derivatives
AU2003278084A1 (en) Benzo(d)azepine derivatives for the treatment of neurological and psychiatric disorders
GB9926968D0 (en) Treatment of neurological disorders
AU2002362115A1 (en) Composition and methods for treatment of neurological disorders
AU5912900A (en) Quinuclidine derivatives for treatment of neurological disorders
AU6076000A (en) Cyclic amine derivatives for the treatment of neurological diseases
AU2080201A (en) Treatment of addiction disorders
SI1468686T1 (en) S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
AU6007900A (en) Azetidine carboxamide derivatives for the treatment of cns disorders
IL136949A0 (en) 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
AU3063800A (en) Drugs for treatment of psychiatric and brain disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase